Insider Selling: Phreesia, Inc. (NYSE:PHR) CFO Sells 3,195 Shares of Stock

Phreesia, Inc. (NYSE:PHR) CFO Balaji Gandhi sold 3,195 shares of the business’s stock in a transaction dated Monday, January 6th. The stock was sold at an average price of $26.61, for a total transaction of $85,018.95. Following the completion of the sale, the chief financial officer now owns 148,509 shares in the company, valued at $3,951,824.49. This represents a 2.11 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Balaji Gandhi also recently made the following trade(s):

• On Tuesday, October 15th, Balaji Gandhi sold 864 shares of Phreesia stock. The shares were sold at an average price of $21.03, for a total transaction of $18,169.92.

Phreesia Stock Performance

NYSE PHR opened at $28.42 on Thursday. The company has a current ratio of 1.74, a quick ratio of 1.77 and a debt-to-equity ratio of 0.04. The company has a market capitalization of $1.65 billion, a PE ratio of -19.33 and a beta of 0.94. The business’s 50-day moving average price is $22.50 and its 200 day moving average price is $22.53. Phreesia, Inc. has a twelve month low of $17.07 and a twelve month high of $29.16.

Phreesia (NYSE:PHR) last announced its quarterly earnings data on Monday, December 9th. The company reported ($0.25) earnings per share for the quarter, topping the consensus estimate of ($0.29) by $0.04. Phreesia had a negative net margin of 20.43% and a negative return on equity of 32.78%. The business had revenue of $106.80 million for the quarter, compared to analyst estimates of $106.33 million. During the same period in the prior year, the firm posted ($0.58) EPS. The company’s revenue was up 16.6% on a year-over-year basis. On average, research analysts predict that Phreesia, Inc. will post -1.16 earnings per share for the current year.

Hedge Funds Weigh In On Phreesia

A number of hedge funds have recently made changes to their positions in the stock. International Assets Investment Management LLC increased its holdings in shares of Phreesia by 2,179.7% during the 3rd quarter. International Assets Investment Management LLC now owns 1,459 shares of the company’s stock worth $33,000 after buying an additional 1,395 shares during the last quarter. Lombard Odier Asset Management USA Corp purchased a new stake in Phreesia during the second quarter valued at about $202,000. Point72 DIFC Ltd purchased a new stake in Phreesia during the second quarter valued at about $209,000. XTX Topco Ltd acquired a new stake in Phreesia during the third quarter worth about $247,000. Finally, Hsbc Holdings PLC acquired a new stake in Phreesia during the 2nd quarter worth approximately $301,000. Institutional investors and hedge funds own 92.10% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have recently commented on PHR shares. JMP Securities reiterated a “market outperform” rating and issued a $30.00 price target on shares of Phreesia in a research report on Tuesday, December 10th. Robert W. Baird lowered their target price on Phreesia from $34.00 to $30.00 and set an “outperform” rating on the stock in a report on Wednesday, December 11th. Royal Bank of Canada raised Phreesia from a “sector perform” rating to an “outperform” rating and raised their price target for the stock from $24.00 to $32.00 in a research report on Wednesday. Truist Financial upped their price objective on Phreesia from $31.00 to $34.00 and gave the company a “buy” rating in a research report on Wednesday, December 11th. Finally, KeyCorp lifted their price objective on Phreesia from $28.00 to $30.00 and gave the stock an “overweight” rating in a research report on Wednesday. Eleven investment analysts have rated the stock with a buy rating, Based on data from MarketBeat, the company has a consensus rating of “Buy” and an average price target of $30.64.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.